Decentralisation, integration, and task-shifting in hepatitis C virus infection testing and treatment: a global systematic review and meta-analysis
Background Increasing access to hepatitis C virus (HCV) care and treatment will require
simplified service delivery models. We aimed to evaluate the effects of decentralisation and …
simplified service delivery models. We aimed to evaluate the effects of decentralisation and …
[PDF][PDF] Innovations in hepatitis C screening and treatment
AA Patel, A Bui, E Prohl, D Bhattacharya… - Hepatology …, 2021 - Wiley Online Library
New therapies offer hope for a cure to millions of persons living with hepatitis C virus (HCV)
infection. HCV elimination is a global goal that will be difficult to achieve using the traditional …
infection. HCV elimination is a global goal that will be difficult to achieve using the traditional …
Recommendations for the management of hepatitis C virus infection among people who inject drugs
In high income countries, the majority of new and existing hepatitis C virus (HCV) infections
occur among people who inject drugs (PWID). In many low and middle income countries …
occur among people who inject drugs (PWID). In many low and middle income countries …
Prevalence and high risk behaviours associated with HCV testing among people who inject drugs: a systematic review and Meta-analysis
Background Hepatitis C diagnosis could be a gateway to behavioral change and
subsequent decline in transmission among people who inject drugs (PWIDs). We assessed …
subsequent decline in transmission among people who inject drugs (PWIDs). We assessed …
Social networks, stigma, and hepatitis C care among women who inject drugs: findings from a community recruited sample
This study explores the role of perceived HCV stigma and social networks on HCV care
among people who inject drugs (PWID) of both sexes, and solely among women who inject …
among people who inject drugs (PWID) of both sexes, and solely among women who inject …
Clinical effectiveness, cost effectiveness and acceptability of community‐based treatment of hepatitis C virus infection: a mixed method systematic review
D Pourmarzi, L Hall, J Hepworth… - Journal of Viral …, 2019 - Wiley Online Library
Several community‐based models for treating hepatitis C virus (HCV) infection have been
implemented to improve treatment accessibility and health outcomes. However, there is a …
implemented to improve treatment accessibility and health outcomes. However, there is a …
CIHR Canadian HIV trials network coinfection and concurrent diseases core research group: 2016 updated Canadian HIV/hepatitis C adult guidelines for …
M Hull, S Shafran, A Wong, A Tseng… - Canadian Journal of …, 2016 - Wiley Online Library
Background. Hepatitis C virus (HCV) coinfection occurs in 20–30% of Canadians living with
HIV and is responsible for a heavy burden of morbidity and mortality. Purpose. To update …
HIV and is responsible for a heavy burden of morbidity and mortality. Purpose. To update …
Expanding access to prevention, care and treatment for hepatitis C virus infection among people who inject drugs.
This special issue contains 16 articles focusing on the epidemiology and prevention of
hepatitis C virus (HCV) infection among people who inject drugs (PWID)(including HCV …
hepatitis C virus (HCV) infection among people who inject drugs (PWID)(including HCV …
Reinfection following successful direct-acting antiviral therapy for HCV infection among people attending an inner-city community health centre in Victoria, Canada
M Selfridge, EB Cunningham, T Barnett, A Drost… - International Journal of …, 2021 - Elsevier
Background Studies of HCV reinfection following direct-acting antiviral (DAA) therapy
among PWID have been limited by short follow-up and small case numbers. This study …
among PWID have been limited by short follow-up and small case numbers. This study …
Hepatitis C virus status awareness and test results confirmation among people who inject drugs in Ukraine
O Iakunchykova, A Meteliuk, A Zelenev… - International journal of …, 2018 - Elsevier
Background Among the estimated 340,000 people who inject drugs (PWID) in Ukraine, HCV
prevalence is approximately 70%. As HCV treatment availability increases, an assessment …
prevalence is approximately 70%. As HCV treatment availability increases, an assessment …